BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33819801)

  • 1. Synthesis, characterization, interactions with 9-MeG and cytotoxic activity of heterobimetallic Ru
    Tsolis T; Nikolaou N; Ypsilantis K; Kougioumtzi A; Kordias D; Magklara A; Garoufis A
    J Inorg Biochem; 2021 Jun; 219():111435. PubMed ID: 33819801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
    Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
    J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
    Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
    J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium(II) p-cymene complex bearing 2,2'-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response.
    Kaluđerović GN; Krajnović T; Momcilovic M; Stosic-Grujicic S; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    J Inorg Biochem; 2015 Dec; 153():315-321. PubMed ID: 26428537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
    Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
    Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
    Bíró L; Farkas E; Buglyó P
    Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru(II)-p-cymene complexes.
    Purkait K; Chatterjee S; Karmakar S; Mukherjee A
    Dalton Trans; 2016 May; 45(20):8541-55. PubMed ID: 27120485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
    Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic Activities of New η
    Ywaya DO; Ibrahim H; Friedrich HB; Bala MD; Soobramoney L; Daniels A; Singh M
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and biological evaluation of cationic organoruthenium(ii) fluorene complexes: influence of the nature of the counteranion.
    Haghdoost MM; Golbaghi G; Guard J; Sielanczyk S; Patten SA; Castonguay A
    Dalton Trans; 2019 Sep; 48(35):13396-13405. PubMed ID: 31432885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.